Clinical Trials are En Route to Eliminating Inaccuracy and Waste by Leveraging AI and Machine Learning

In the traditional world of drug development, research happens in separate bubbles and exists in silos. Unfortunately, this separation of information slows overall progress and testing. The company VeriSIM Life is utilizing AI and machine learning to combine data and speed up drug development. 

“I always enjoyed challenging problems and how to solve them,” said Dr. Jo Varshney, Founder, and CEO of VeriSIM Life. Dr. Varshney became involved in drug development after feeling limited by the reactiveness of traditional medicine. “Testing in rats and then saying it will work in humans is a hard thing to feel OK about. That caution became a big driving factor in life,” said Dr. Varshney.  

The machine learning from VeriSIM is called BioSIM. It uses existing test results and predicts how different medicines and compounds will impact a test subject. It imitates the biological reality of the living. Dr. Varshney said they try to create virtual imprints of behaviors we see between different animals.  

An integrated approach is critical to rapid drug advances. According to Genetic Engineering and Biotechnology News, “in drug development, speed is cultivating collaborative relationships, enabling data-driven workflows.” With BioSIM, the data is collected, computed, and identifies patterns. The technology leverages the drug development strategy to predict the best next step.  

Even in the earliest stages of development, when there might not be any animal data, the system can predict outcomes based solely on compounds. “What we call the three Rs. Reduction, refinement, and replacement of certain animal experiments,” said Dr. Varshney. “That’s the beauty of machine learning and AI. It’s the computation, learning, and identifying patterns.” 

Follow us on social media for the latest updates in B2B!



air quality
Superior Air Quality and HVAC Systems are Crucial for Senior Care
May 29, 2024

The demographic shift towards an aging population, projected to reach 27 million Americans in nursing and assisted living facilities by 2050, raises significant concerns about indoor air quality in these environments. With respiratory health already being a critical issue among seniors, the stakes are high for ensuring that HVAC systems are up to par….

Read More
Trades industry
The Future of Data Centers: Cooling, Power, and ESG with Saqib Ashraf
May 28, 2024

In a rapidly evolving data center industry, cooling technologies are finally taking center stage, driven by the rise of AI and other high-density computing needs. In the latest episode of Straight Outta Crumpton, Saqib Ashraf, Director of Solutions Architecture at CPG, shares insights on the future of data centers as well as the challenges…

Read More
With Walmart Health Shuttering Its Doors, Retail Healthcare Has to Rethink Its Role & Strategy in Primary Care
May 28, 2024

Retail healthcare is an uncertain slice of the U.S. healthcare industry, being defined by both recent strategic retreats and bold expansions which have sparked crucial discussions about the future of primary care services within the retail sector. The most recent news that shocked the industry was the shuttering of Walmart Health, Walmart’s 51 health…

Read More
Edge Computing Smart Cities Experts Talk
Edge Computing is the Foundation for Scaled Smart Cities. How Can the Industry Accelerate Adoption?
May 28, 2024

As cities globally accelerate their transformation into “smart cities,” the integration of a capable computing ecosystem to complement smart city initiatives has become an important part of smart city success. How critical will edge computing be in that ecosystem, and in the facilitation of today’s and tomorrow’s smart city projects, especially with where smart…

Read More